IB
Incyclix Bio
NC - Durham
BiotechnologyFocus: Precision treatments that target the aberrant proliferation driving many cancers
Incyclix Bio is a life sciences company focused on Precision treatments that target the aberrant proliferation driving many cancers.
Oncology
Funding Stage
SERIES B
Open Jobs
0
Pipeline & Clinical Trials
INX-315
Breast CancerClinical Trials (1)
NCT05735080Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Phase 1/2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 1 clinical trial